Jardiance (empagliflozin)

empagliflozin · Boehringer Ingelheim; Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Jardiance (empagliflozin), covering 2014-06-16 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus [Phase 2]

See pricing